Literature DB >> 25038545

Induced regulatory T-cells (iTregs) generated by activation with anti-CD3/CD28 antibodies differ from those generated by the physiological-like activation with antigen/APC.

Chan Zhao1, Guangpu Shi2, Barbara P Vistica2, Samuel J H Hinshaw2, Wambui S Wandu2, Cuiyan Tan2, Meifen Zhang3, Igal Gery4.   

Abstract

Regulatory T-cells (Tregs) are responsible for homeostasis of the immune system, as well as for inhibition of pathogenic autoimmune processes. Induced-(i)-Tregs, can be generated in vitro by activation of CD4 cells in the presence of TGF-β. A commonly used activation mechanism is by antibodies against CD3 and CD28. The physiological-like activation of T-cells, however, is with the specific target antigen presented by antigen-presenting cells (APC). The two modes of activation have been considered to yield the same populations of iTregs. Here, we compared between iTreg populations generated by either one of the two methods and found differences between their capacities to inhibit T-lymphocyte proliferative response, their expression of cell surface antigens and particularly, in their transcript expression profiles of certain chemokines and chemokine receptors. Our data thus indicate that iTregs generated by activation with anti-CD3/CD28 antibodies cannot be considered identical to iTregs generated by antigen/APC. Published by Elsevier Inc.

Entities:  

Keywords:  Cell adhesion molecules; Proliferation assay; T cell activation; T regulatory (Treg) cells; TCR transgenic

Mesh:

Substances:

Year:  2014        PMID: 25038545     DOI: 10.1016/j.cellimm.2014.06.004

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

1.  Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.

Authors:  Majid Jaberi-Douraki; Massimo Pietropaolo; Anmar Khadra
Journal:  J Theor Biol       Date:  2015-08-10       Impact factor: 2.691

2.  Zinc supplementation induces CD4+CD25+Foxp3+ antigen-specific regulatory T cells and suppresses IFN-γ production by upregulation of Foxp3 and KLF-10 and downregulation of IRF-1.

Authors:  Martina Maywald; Lothar Rink
Journal:  Eur J Nutr       Date:  2016-06-03       Impact factor: 5.614

3.  CD8(+) Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4(+) Tregs in mice.

Authors:  Jessica Heinrichs; Jun Li; Hung Nguyen; Yongxia Wu; David Bastian; Anusara Daethanasanmak; M-Hanief Sofi; Steven Schutt; Chen Liu; Junfei Jin; Brian Betts; Claudio Anasetti; Xue-Zhong Yu
Journal:  Oncoimmunology       Date:  2016-03-28       Impact factor: 8.110

4.  Regulatory T-Cell Therapy for Graft-versus-host Disease.

Authors:  Jessica Heinrichs; David Bastian; Anandharaman Veerapathran; Claudio Anasetti; Brain Betts; Xue-Zhong Yu
Journal:  J Immunol Res Ther       Date:  2016-04-28

5.  Triptolide Inhibits Osteoclast Differentiation and Bone Resorption In Vitro via Enhancing the Production of IL-10 and TGF-β1 by Regulatory T Cells.

Authors:  Huihui Xu; Hongyan Zhao; Cheng Lu; Qi Qiu; Gui Wang; Jing Huang; Minghui Guo; Baosheng Guo; Yong Tan; Cheng Xiao
Journal:  Mediators Inflamm       Date:  2016-06-19       Impact factor: 4.711

6.  Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance.

Authors:  Marta Consuegra-Fernández; Mario Martínez-Florensa; Fernando Aranda; José de Salort; Noelia Armiger-Borràs; Teresa Lozano; Noelia Casares; Juan José Lasarte; Pablo Engel; Francisco Lozano
Journal:  Front Immunol       Date:  2017-05-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.